Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
21.27
-0.19 (-0.89%)
Jan 29, 2026, 10:14 AM EST - Market open

Enovis Revenue

Enovis had revenue of $548.91M in the quarter ending October 3, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $2.23B, up 11.57% year-over-year. In the year 2024, Enovis had annual revenue of $2.11B with 23.46% growth.

Revenue (ttm)
$2.23B
Revenue Growth
+11.57%
P/S Ratio
0.55
Revenue / Employee
$303,145
Employees
7,367
Market Cap
1.22B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.11B400.43M23.46%
Dec 31, 20231.71B144.10M9.22%
Dec 31, 20221.56B136.91M9.60%
Dec 31, 20211.43B305.49M27.26%
Dec 31, 20201.12B-2.21B-66.32%
Dec 31, 20193.33B1.13B51.73%
Dec 31, 20182.19B255.80M13.20%
Dec 31, 20171.94B-1.25B-39.19%
Dec 31, 20163.19B-248.60M-7.24%
Dec 31, 20153.43B-1.19B-25.74%
Dec 31, 20144.62B417.27M9.92%
Dec 31, 20134.21B293.35M7.50%
Dec 31, 20123.91B3.22B464.45%
Dec 31, 2011693.39M151.41M27.94%
Dec 31, 2010541.99M16.96M3.23%
Dec 31, 2009525.02M-79.83M-13.20%
Dec 31, 2008604.85M98.55M19.46%
Dec 31, 2007506.31M112.70M28.63%
Dec 31, 2006393.60M48.13M13.93%
Dec 31, 2005345.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AdaptHealth3.26B
Integra LifeSciences Holdings1.64B
CONMED1.35B
Tandem Diabetes Care1.01B
NovoCure642.27M
InMode364.49M
PROCEPT BioRobotics299.91M
Axogen214.71M
Revenue Rankings